Asia Beat: Famine or feast as Japan debates pricing reforms?
This article was originally published in Scrip
Recent official discussions in Japan are hinting at the shape of the revised reimbursement policies likely to be adopted at the time of the country's next regular drug price revision in April 2014.
You may also be interested in...
Also, deals involving Sumitomo Dainippon, Tolero, Boston Biomedical, Zai Lab, Turning Point, SciClone, EpicentRx, Yuhan, GI Innovation, Takeda, Carmine, HitGen, Morphic, CStone and Burning Rock.
US pharma giant joins Singapore alliance aiming to encourage regional startups and innovation, in multiple tech-related areas including digital health, through the provision of expertise and support.
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.